Australias CSL reports half-year profit jump on strong demand for immunoglobulin products
Australias biotech giant CSL Ltd reported a 5% rise in its first-half profit on Tuesday, boosted by growth in its…
136,420€
1,84%
Echtzeit-Aktienkurs CSL Ltd.
Bid:
Ask: